Martindale Pharmaceuticals has informed the UK Medicines and Healthcare products Regulatory Agency (MHRA) that a linear barcode error has been identified in some batches of its Clobazam oral suspension, available in 5 mg/5 mL and 10 mg/5 mL strengths in 150 mL bottles.
The issue pertains to the barcode labeling and may affect product identification; further details are available from the MHRA alert.
Actualités réglementaires17 sept. 2026•3 min de lecture
MHRA notified of barcode error in Martindale Clobazam oral suspension batches
Martindale Pharmaceuticals reported a linear barcode error affecting certain batches of Clobazam 5 mg/5 mL and 10 mg/5 mL oral suspension (150 mL) to the MHRA.
Compilé par l'équipe Pharmacountry · Source : MHRA
Sujets :
Évaluations
(0)
(0)
(0)
(0)
(0)
Laissez votre note